[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:chronic-fatigue-syndrome":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":140,"states":141},"Chronic Fatigue Syndrome",21,12,[8,15,21,28,34,40,47,54,60,66,72,79,84,91,97,103,110,116,122,129,134],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT07009691","Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME\u002FCFS",[],"RECRUITING","2026-08-26T02:16:44.178623Z","2026-05-05T02:43:29.013456Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT07523113","ME\u002FCFS Brain Fog: Cognitive Rehabilitation Trial",[],"2026-08-26T02:16:31.714843Z","2026-05-05T02:43:28.619226Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":26,"content_modified":27},"NCT06211062","The Use of Directed Probiotics in ME\u002FCFS: Myalgic Encephalomyelitis\u002FChronic Fatigue Syndrome",[25],"Phase 2","2026-08-26T02:15:44.309045Z","2026-05-05T02:43:27.494866Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":32,"content_modified":33},"NCT06366724","LIFT: Life Improvement Trial",[25],"2026-08-26T02:19:04.543908Z","2026-05-05T02:43:26.683913Z",{"nct_id":35,"title":36,"phases":37,"status":12,"updated_at":38,"content_modified":39},"NCT04556890","Pain and Major Depressive Disorder",[],"2026-08-26T02:16:46.951087Z","2026-05-05T02:43:29.679876Z",{"nct_id":41,"title":42,"phases":43,"status":12,"updated_at":45,"content_modified":46},"NCT06511050","Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis\u002FChronic Fatigue Syndrome",[44],"Phase 1\u002FPhase 2","2026-08-26T02:16:34.792807Z","2026-05-05T02:43:27.804378Z",{"nct_id":48,"title":49,"phases":50,"status":12,"updated_at":52,"content_modified":53},"NCT03759522","Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.",[51],"Phase 1","2026-08-26T02:15:31.806698Z","2026-05-05T02:43:26.682783Z",{"nct_id":55,"title":56,"phases":57,"status":12,"updated_at":58,"content_modified":59},"NCT07551999","A Study Of Remote Voice Analysis Tool For Diagnosing And Monitoring ME\u002FCFS",[],"2026-08-26T02:17:42.501124Z","2026-05-13T02:55:06.721067Z",{"nct_id":61,"title":62,"phases":63,"status":12,"updated_at":64,"content_modified":65},"NCT07227441","Chronic Infections and Inflammation in ME\u002FCFS: An Observational Study",[],"2026-08-26T02:17:11.311767Z","2026-05-13T02:55:06.678659Z",{"nct_id":67,"title":68,"phases":69,"status":12,"updated_at":70,"content_modified":71},"NCT04806620","Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research",[],"2026-08-26T02:16:01.910993Z","2026-05-13T02:55:06.271836Z",{"nct_id":73,"title":74,"phases":75,"status":12,"updated_at":77,"content_modified":78},"NCT06472622","Functional Neuroimaging to Detect the Neural Signatures of the Unpleasantness of Pain and Effort",[76],"Early Phase 1","2026-08-26T02:15:25.633039Z","2026-05-05T02:43:29.167522Z",{"nct_id":80,"title":81,"phases":82,"status":12,"updated_at":26,"content_modified":83},"NCT05741112","The Long COVID-19 Wearable Device Study",[],"2026-05-05T02:43:27.245853Z",{"nct_id":85,"title":86,"phases":87,"status":88,"updated_at":89,"content_modified":90},"NCT07285473","Low-Dose Naltrexone For ME\u002FCFS: Dose-Finding",[25],"NOT_YET_RECRUITING","2026-08-26T02:16:55.892527Z","2026-05-05T02:43:29.217509Z",{"nct_id":92,"title":93,"phases":94,"status":88,"updated_at":95,"content_modified":96},"NCT05967494","Discovering Trends in Chronic Fatigue Syndrome Patients' Clinical Study Experiences",[],"2026-08-26T02:15:28.524219Z","2026-05-13T02:55:06.397165Z",{"nct_id":98,"title":99,"phases":100,"status":88,"updated_at":101,"content_modified":102},"NCT07600320","Fareon Open Label Device Clinical Trial",[],"2026-08-26T02:18:41.390601Z","2026-05-29T15:36:40.219517Z",{"nct_id":104,"title":105,"phases":106,"status":107,"updated_at":108,"content_modified":109},"NCT07256795","Blood-Brain Barrier Integrity and Immune Dynamics in Neuropsychiatric Sequelae of Post-SARS-CoV-2 Onset ME\u002FCFS Versus Pre-Pandemic ME\u002FCFS Patients",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:10.529598Z","2026-06-16T05:54:07.877242Z",{"nct_id":111,"title":112,"phases":113,"status":107,"updated_at":114,"content_modified":115},"NCT06257420","Low Dose Rapamycin in ME\u002FCFS, Long-COVID, and Other Infection Associated Chronic Conditions",[],"2026-08-26T02:16:07.529922Z","2026-06-16T05:54:07.720735Z",{"nct_id":117,"title":118,"phases":119,"status":107,"updated_at":120,"content_modified":121},"NCT06583395","Quest to Analyze One Thousand Humans Meditating",[],"2026-08-26T02:16:16.995720Z","2026-06-16T05:54:07.763563Z",{"nct_id":123,"title":124,"phases":125,"status":126,"updated_at":127,"content_modified":128},"NCT06585254","tVNS in Long COVID-19",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:37:48.267540Z","2026-05-05T02:43:27.741739Z",{"nct_id":130,"title":131,"phases":132,"status":126,"updated_at":127,"content_modified":133},"NCT03952624","Patient-Centered Assessment of Symptoms and Outcomes",[],"2026-05-13T02:55:06.180902Z",{"nct_id":135,"title":136,"phases":137,"status":126,"updated_at":138,"content_modified":139},"NCT04542161","Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis\u002FChronic Fatigue Syndrome",[25],"2026-08-03T02:33:50.324958Z","2026-05-05T02:43:27.658729Z",[],[142,146,150,154],{"state":143,"count":144,"slug":145},"California",6,"california",{"state":147,"count":148,"slug":149},"New York",5,"new-york",{"state":151,"count":152,"slug":153},"Alabama",3,"alabama",{"state":155,"count":152,"slug":156},"Maryland","maryland"]